Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.

The oncologist - 7 Sept 2023

Liu Man, Li Na, Tang Hongzhen, Chen Luohai, Liu Xuemei, Wang Yu, Lin Yuan, Luo Yanji, Wei Shaozhen, Wen Wenli, Chen Minhu, Wang Jiaqian, Zhang Ning, Chen Jie

Abstract excerpt

BACKGROUND: Neuroendocrine neoplasms (NENs) represent clinically and genetically heterogeneous malignancies, thus a comprehensive understanding of underlying molecular characteristics, prognostic signatures, and potential therapeutic targets is urgently needed. METHODS: Next-generation sequencing (NGS) and immunohistochemistry were applied to acquire genomic and immune profiles of NENs from 47 patients. RESULTS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Neuroendocrine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Cancer Research Studies

Share to Mutation

Share to Neuroendocrine Tumor Research Advances

Share to Neuroendocrine Tumors

Share to Pancreatic Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 37086484
DOI: 10.1093/oncolo/oyad093
PMCID: PMC10485279

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.PMID 37086484Read ↗

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.Semantic proximity Read ↗

Genetic and epigenetic drivers of neuroendocrine tumours (NET)Semantic proximity Read ↗

Genomic Profiling and Clinicopathological Characteristics of Neuroendocrine Tumors of the Lung in East Asian Patients.Semantic proximity Read ↗

Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasmsSemantic proximity Read ↗

Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges.Semantic proximity Read ↗

In-depth analysis of the genomic landscape of 86 metastatic neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targetsSemantic proximity Read ↗

Blood-based next-generation sequencing analysis of neuroendocrine neoplasmsSemantic proximity Read ↗

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.Semantic proximity Read ↗

Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implicationsSemantic proximity Read ↗

Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?Semantic proximity Read ↗

Genetic alterations of GI-NECs involving three main signaling pathways.Semantic proximity Read ↗

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.